Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stem cell infusions show promise for long COVID sufferers

NCT ID NCT05126563

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 36 times

Summary

This study tested whether stem cell infusions could help people with chronic post-COVID syndrome (Long COVID). 79 adults received four doses of either stem cells or a placebo over 10 weeks. Researchers tracked changes in symptoms like extreme fatigue, brain fog, headaches, and sleep problems using simple rating scales. The goal was to see if the treatment could safely reduce these lingering symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-COVID-19 SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hope Biosciences Research Foundation

    Sugar Land, Texas, 77478, United States

Conditions

Explore the condition pages connected to this study.